349 related articles for article (PubMed ID: 22713662)
1. Targeting radiation-resistant hypoxic tumour cells through ATR inhibition.
Pires IM; Olcina MM; Anbalagan S; Pollard JR; Reaper PM; Charlton PA; McKenna WG; Hammond EM
Br J Cancer; 2012 Jul; 107(2):291-9. PubMed ID: 22713662
[TBL] [Abstract][Full Text] [Related]
2. The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy.
Prevo R; Fokas E; Reaper PM; Charlton PA; Pollard JR; McKenna WG; Muschel RJ; Brunner TB
Cancer Biol Ther; 2012 Sep; 13(11):1072-81. PubMed ID: 22825331
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of ATR leads to increased sensitivity to hypoxia/reoxygenation.
Hammond EM; Dorie MJ; Giaccia AJ
Cancer Res; 2004 Sep; 64(18):6556-62. PubMed ID: 15374968
[TBL] [Abstract][Full Text] [Related]
4. Hsp90 inhibitor-mediated disruption of chaperone association of ATR with hsp90 sensitizes cancer cells to DNA damage.
Ha K; Fiskus W; Rao R; Balusu R; Venkannagari S; Nalabothula NR; Bhalla KN
Mol Cancer Ther; 2011 Jul; 10(7):1194-206. PubMed ID: 21566061
[TBL] [Abstract][Full Text] [Related]
5. Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation.
Fokas E; Prevo R; Pollard JR; Reaper PM; Charlton PA; Cornelissen B; Vallis KA; Hammond EM; Olcina MM; Gillies McKenna W; Muschel RJ; Brunner TB
Cell Death Dis; 2012 Dec; 3(12):e441. PubMed ID: 23222511
[TBL] [Abstract][Full Text] [Related]
6. ATR inhibition broadly sensitizes ovarian cancer cells to chemotherapy independent of BRCA status.
Huntoon CJ; Flatten KS; Wahner Hendrickson AE; Huehls AM; Sutor SL; Kaufmann SH; Karnitz LM
Cancer Res; 2013 Jun; 73(12):3683-91. PubMed ID: 23548269
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia links ATR and p53 through replication arrest.
Hammond EM; Denko NC; Dorie MJ; Abraham RT; Giaccia AJ
Mol Cell Biol; 2002 Mar; 22(6):1834-43. PubMed ID: 11865061
[TBL] [Abstract][Full Text] [Related]
8. ATR controls cellular adaptation to hypoxia through positive regulation of hypoxia-inducible factor 1 (HIF-1) expression.
Fallone F; Britton S; Nieto L; Salles B; Muller C
Oncogene; 2013 Sep; 32(37):4387-96. PubMed ID: 23085754
[TBL] [Abstract][Full Text] [Related]
9. Radio-sensitizing effects of VE-821 and beyond: Distinct phosphoproteomic and metabolomic changes after ATR inhibition in irradiated MOLT-4 cells.
Šalovská B; Janečková H; Fabrik I; Karlíková R; Čecháková L; Ondrej M; Link M; Friedecký D; Tichý A
PLoS One; 2018; 13(7):e0199349. PubMed ID: 30001349
[TBL] [Abstract][Full Text] [Related]
10. Dynamic inhibition of ATM kinase provides a strategy for glioblastoma multiforme radiosensitization and growth control.
Golding SE; Rosenberg E; Adams BR; Wignarajah S; Beckta JM; O'Connor MJ; Valerie K
Cell Cycle; 2012 Mar; 11(6):1167-73. PubMed ID: 22370485
[TBL] [Abstract][Full Text] [Related]
11. ZEB1 inhibition sensitizes cells to the ATR inhibitor VE-821 by abrogating epithelial-mesenchymal transition and enhancing DNA damage.
Song N; Jing W; Li C; Bai M; Cheng Y; Li H; Hou K; Li Y; Wang K; Li Z; Liu Y; Qu X; Che X
Cell Cycle; 2018; 17(5):595-604. PubMed ID: 29157079
[TBL] [Abstract][Full Text] [Related]
12. Comparison of hypoxia-induced replication arrest with hydroxyurea and aphidicolin-induced arrest.
Hammond EM; Green SL; Giaccia AJ
Mutat Res; 2003 Nov; 532(1-2):205-13. PubMed ID: 14643437
[TBL] [Abstract][Full Text] [Related]
13. HIF1-regulated ATRIP expression is required for hypoxia induced ATR activation.
Ding G; Liu HD; Liang HX; Ni RF; Ding ZY; Ni GY; Hua HW; Xu WG
FEBS Lett; 2013 Apr; 587(7):930-5. PubMed ID: 23454212
[TBL] [Abstract][Full Text] [Related]
14. Ataxia telangiectasia and Rad3-related overexpressing cancer cells induce prolonged G₂ arrest and develop resistance to ionizing radiation.
Kim YM; Lee YM; Park SY; Pyo H
DNA Cell Biol; 2011 Apr; 30(4):219-27. PubMed ID: 21294646
[TBL] [Abstract][Full Text] [Related]
15. Roles of Kruppel-associated Box (KRAB)-associated Co-repressor KAP1 Ser-473 Phosphorylation in DNA Damage Response.
Hu C; Zhang S; Gao X; Gao X; Xu X; Lv Y; Zhang Y; Zhu Z; Zhang C; Li Q; Wong J; Cui Y; Zhang W; Ma L; Wang C
J Biol Chem; 2012 Jun; 287(23):18937-52. PubMed ID: 22496453
[TBL] [Abstract][Full Text] [Related]
16. Replication independent ATR signalling leads to G2/M arrest requiring Nbs1, 53BP1 and MDC1.
Stiff T; Cerosaletti K; Concannon P; O'Driscoll M; Jeggo PA
Hum Mol Genet; 2008 Oct; 17(20):3247-53. PubMed ID: 18664457
[TBL] [Abstract][Full Text] [Related]
17. Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR.
Reaper PM; Griffiths MR; Long JM; Charrier JD; Maccormick S; Charlton PA; Golec JM; Pollard JR
Nat Chem Biol; 2011 Apr; 7(7):428-30. PubMed ID: 21490603
[TBL] [Abstract][Full Text] [Related]
18. Ionizing radiation-dependent gamma-H2AX focus formation requires ataxia telangiectasia mutated and ataxia telangiectasia mutated and Rad3-related.
Friesner JD; Liu B; Culligan K; Britt AB
Mol Biol Cell; 2005 May; 16(5):2566-76. PubMed ID: 15772150
[TBL] [Abstract][Full Text] [Related]
19. Requirement of MTA1 in ATR-mediated DNA damage checkpoint function.
Li DQ; Ohshiro K; Khan MN; Kumar R
J Biol Chem; 2010 Jun; 285(26):19802-12. PubMed ID: 20427275
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of ATR-dependent signaling by protoapigenone and its derivative sensitizes cancer cells to interstrand cross-link-generating agents in vitro and in vivo.
Wang HC; Lee AY; Chou WC; Wu CC; Tseng CN; Liu KY; Lin WL; Chang FR; Chuang DW; Hunyadi A; Wu YC
Mol Cancer Ther; 2012 Jul; 11(7):1443-53. PubMed ID: 22532598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
